The healthcare provider, which has become an increasingly active investor, has formed a corporate venturing unit called Cigna Ventures.

Ten businesses will receive $52,000 in grant funding for participating in a Francis Crick-operated accelerator for data science-powered biomedical interfaces.

University of Melbourne and Lockheed Martin have contributed to an additional $94.8m tranche for the Csiro Innovation Fund, bringing its total to $167m.

Series A investors Pfizer Venture Investments and Roche Venture Fund have returned for a $10m round three years later.

Alexandria Venture Investments led a series C round that included existing investors Pfizer Ventures and Roche Venture Fund.

Blue Cross Blue Shield of Massachusetts and Blue Cross and Blue Shield of Kansas both backed a round that boosted the heart monitor developer's total financing to $77m.

The GlaxoSmithKline-backed immunotherapy developer closed an oversubscribed round that took its total funding to approximately $226m.

Elevian will commercialise research from Harvard and Stanford indicating young blood cells could be used to restore tissues in older patients.

Helsinn Investment Fund and Alexandria Venture Investments both invested as MD Anderson-backed OncoResponse looks to advance five immuno-oncology drug candidates.